Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Country: Europe
  • Remove this filter Public health area: Vaccine safety
  • Remove this filter Public health area: Active immunisation
  • Infectious disease
    • Vaccine preventable diseases (16)
    • Respiratory diseases (12)
    • Influenza (12)
    • Influenza in humans, seasonal (11)
    • Seasonal influenza (11)
    • Flu (11)
    • Influenza A (H1N1)2009 (10)
    • Influenza A (H1N1) (10)
    • Influenza in humans, pandemic (5)
    • Rotavirus infection (2)
    • Mosquito-borne diseases (1)
    • Measles (1)
    • Mumps (1)
    • Congenital rubella (1)
    • Guillain-Barré syndrome (1)
  • Public health area
    • Active immunisation (17)
    • Vaccine safety (17)
    • Vaccination (17)
    • Immunisation (17)
    • Vaccine effectiveness (3)
    • Vaccine hesitancy (3)
    • Epidemiology (2)
    • Epidemic (2)
    • Health communication (2)
    • Pandemic preparedness (2)
    • Vaccine efficacy (2)
    • Vaccination coverage (2)
    • Surveillance (1)
    • Molecular typing (1)
    • Prevention and control (1)
    • Risk communication (1)
    • Scientific advice (1)
    • Determinant (1)
    • Microbiology (1)
    • Burden of communicable diseases (1)
    • Hospital infection control (1)
    • Disease prevention (1)
    • Prophylaxis (1)
    • Crisis communication (1)
  • Country
    • Europe (17)
      • EU/EEA (10)
      • European Union Member State/European Economic Area (6)
      • Finland (3)
      • Ireland (1)
      • Sweden (1)
  • Type
    • News (9)
    • ECDC comment (8)
    • Publication (6)
    • Technical report (3)
    • Peer-reviewed publication (2)
    • Expert opinion (1)
    • Event (1)
    • External link (1)
  • Page 1 of 2 // 17 Results found
    • Sort by:

Publication

Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation

Technical report - 20 Sep 2012

This report summarises the results from two epidemiological studies conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium undertaken in eight European Union (EU)/European Economic Area (EEA) countries in order to investigate a possible association between an unexpected increase in narcolepsy cases following the use of influenza A(H1N1)pdm09 vaccines. Narcolepsy is an underdiagnosed disease of widely unknown etiology.

Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation - EN - [PDF-8 MB]
  • EU/EEA
  • Europe
  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

Publication

Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination

Technical report - 20 Sep 2012

This report summarises the results from two epidemiological studies to investigate a possible association between an unexpected increase in narcolepsy cases following the use of the influenza A(H1N1)pdm09 vaccines. The studies were conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium under the auspices of ECDC and undertaken in Denmark, Finland, France, Italy, the Netherlands, Norway, Sweden and the United Kingdom. This Technical Report In Brief accompanies the full Report ‘Narcolepsy in association with pandemic influenza vaccination- A multi-country European epidemiological investigation’.

Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination - EN - [PDF-293.03 KB]
  • Europe
  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

Publication

Vaccine hesitancy among healthcare workers and their patients in Europe

Technical report - 19 Oct 2015

The aim of this research project is to have a better understanding of vaccine hesitancy and safety concerns among healthcare vaccine providers and their patients in Europe and to explore the link and potential influence between the two groups.

Vaccine hesitancy among healthcare workers and their patients in Europe - EN - [PDF-1.19 MB]
  • Europe
  • Immunisation
  • Vaccine hesitancy
  • Vaccine preventable diseases
  • Vaccine safety
Oct 2015

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

Event
23 Oct 2015
Geneva, Switzerland
International Alliance for Biological Standardisation and the World Health Organization

​This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.

  • EU/EEA
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccine safety

News

Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescentsArchived

ECDC comment - 1 Jul 2011

ECDC has previously summarised information concerning the appearance of narcolepsy following the use of a specific pandemic vaccine (Pandemrix®) in children and adolescents in three European Countries.

  • Europe
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived

ECDC comment - 13 Jul 2011

Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North  America (3) following the 2009 influenza pandemic vaccination campaigns.

  • Europe
  • Guillain-Barré syndrome
  • Immunisation
  • Influenza in humans, pandemic
  • Pandemic preparedness
  • Vaccine preventable diseases
  • Vaccine safety

News

Recommendation by the European Medicines Agency concerning Pandemrix vaccination and reports of narcolepsy in children and adolescentsArchived

ECDC comment - 21 Jul 2011

EMA recommends restricting use in persons under 20 years of age Pandemrix to be used only in the absence of seasonal trivalent influenza vaccines, following link to very rare cases of narcolepsy in young people. Overall benefit-risk remains positive.

  • EU/EEA
  • Immunisation
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine preventable diseases
  • Vaccine safety

News

Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb StudyArchived

ECDC comment - 1 Feb 2012

Results of this study demonstrated that the RIX4414 vaccine was well tolerated and immunogenic in pre-term European infants: more than 75% of infants had seroconverted 30-83 days after dose 2.

  • Europe
  • Immunisation
  • Rotavirus infection
  • Vaccine safety

News

Association of childhood narcolepsy and cataplexy and receipt of a pandemic influenza vaccine in Finland in 2009-10 – First papers in a peer review journalArchived

ECDC comment - 30 Mar 2012

​A pair of linked papers from Finland concerning the above topic, one epidemiological and the second combining both clinical and epidemiological were published on March 28th in the open access journal, PLoS One.(1,2).

  • Finland
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • Vaccine safety

News

Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of IrelandArchived

ECDC comment - 19 Apr 2012

Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 - Final Report of National Narcolepsy Study Steering Committee, Department of Health, Ireland

  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Ireland
  • Vaccine safety

Pagination

  • Current page 1
  • Page 2
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us